Furthermore, AML is associated with certain gene mutations, with FMS-related tyrosine kinase 3 internal tandem duplications (Flt3-ITD; adverse prognosis) and nucleophosmin (NPM1; favorable prognosis) mutations being the most significant [4]. This evidence concerns the gene FLT3 and acute myeloid leukemia.